COMMUNIQUÉS West-GlobeNewswire

Chimerix Presents Results from Multiple Ascending Dose Study of IV Brincidofovir at IDWeek
05/10/2018
DURHAM, N.C., Oct. 05, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced data from the company’s Phase 1 study [...]
Protalix BioTherapeutics Presents Positive Preliminary Data from the BRIDGE Study of pegunigalsidase alfa for the Treatment of Fabry Disease at the 1st Canadian Symposium on Lysosomal Diseases 2018
05/10/2018
~Preliminary Results Indicate Significant Improvement in Kidney Function in Patients Switched from agalsidase alfa (Replagal®) to pegunigalsidase alfa (PRX-102)~ A deterioration trend in patients’ kidney function on [...]
Calithera Biosciences Announces Clinical Trial Collaboration to Evaluate IBRANCE® (palbociclib) and talazoparib in Combination with CB-839
05/10/2018
Phase 1/2 trials expected to initiate 1Q2019 SOUTH SAN FRANCISCO, Calif., Oct. 05, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on the development [...]
Amicus Therapeutics Announces Positive 18-Month Data in Pompe Disease Phase 1/2 Study at 23rd International Annual Congress of the World Muscle Society
05/10/2018
Consistent and Durable Responses Across Key Measures of Safety, Functional Outcomes and Biomarkers Continue Out to Month 18 for both ERT-Naïve and ERT-Switch Patients Very Low Rate (<1%) of Infusion Associated [...]
T2 Biosystems Reports Granting of Inducement Awards
05/10/2018
LEXINGTON, Mass., Oct. 05, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in healthcare, [...]
Canada House Wellness Group Inc Announces Scott Purdy’s Departure
05/10/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Oct. 05, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc ("Canada House" or the "Company") (CSE: CHV) announces that [...]
K2M Group Holdings, Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders
05/10/2018
LEESBURG, Va., Oct. 05, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (Nasdaq: KTWO) (the “Company” or “K2M”), announced today that it has set a record date and meeting date for a special meeting of its stockholders [...]
RadNet Enters the Long Island, New York Market with the Acquisition of Medical Arts Radiology
05/10/2018
LOS ANGELES, Oct. 05, 2018 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services today reported it acquired [...]
RavenQuest Engages Link Media LLC to Provide Market Awareness to the USA Market
05/10/2018
VANCOUVER, British Columbia, Oct. 05, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) RavenQuest BioMed Inc. has retained Link Media LLC to [...]
Healthy Stomach Day – aroused wide interest and increased awareness on stomach health
05/10/2018
Press release 5th of October 2018 at 12.10 PM local time International Healthy Stomach Initiative (HSI) organized on Tuesday, October 2, 2018 in several countries all over the world public events aiming to increase the [...]
Terveystalo Plc: The Finnish Competition and Consumer Authority applies for an extension for investigating the transaction between Terveystalo and Attendo
05/10/2018
Terveystalo Plc Stock Exchange release 5 October 2018 at 09:00 a.m EEST Terveystalo Plc ("Terveystalo") has on 17 May 2018 signed an agreement to acquire the Finnish healthcare operations of Attendo AB (publ) ("Attendo [...]
Rule 2.9 Announcement
05/10/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 5 October 2018 [...]
VALNEVA Announces FDA Approval of Accelerated IXIARO® Vaccination Schedule
05/10/2018
Valneva Announces FDA Approval of Accelerated IXIARO ® Vaccination Schedule Saint Herblain (France), October 5, 2018 - Valneva SE ("Valneva" or "the Company"), a commercial stage biotech company focused on developing [...]
VALNEVA : la FDA approuve un schéma accéléré de vaccination pour IXIARO®
05/10/2018
Valneva: la FDA approuve un schéma accéléré de vaccination pour IXIARO ® Saint Herblain (France), 5 octobre 2018 - Valneva SE ("Valneva" ou "le Groupe"), société de biotechnologie dédiée au développement, à la [...]
Probiodrug Reports Management Changes
05/10/2018
Probiodrug Reports Management Changes HALLE (SAALE), Germany, October 5th, 2018 - Probiodrug AG ("Probiodrug", Euronext: PBD), a clinical stage biopharmaceutical company developing novel therapeutic solutions to treat [...]
ObsEva SA Announces Phase 3 IMPLANT 2 Clinical Trial Results of Nolasiban in IVF to be Presented at Annual ASRM Meeting Tuesday October 9, 2018
05/10/2018
Recipient of Prize Paper Award from the Society for Assisted Reproductive Technology (SART) Geneva, Switzerland and Boston, MA - October 5, 2018 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage [...]
Canada House Wellness Group Inc. Announces Closing of First Tranche under Alumina Facility
05/10/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Oct. 04, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc ("Canada House" or the "Company") (CSE: CHV) is pleased to [...]
MediciNova Announces FDA Grants Orphan Drug Designation to MN-166 (ibudilast) for Glioblastoma
05/10/2018
LA JOLLA, Calif., Oct. 04, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), [...]
Emergent BioSolutions Completes Acquisition of Specialty Vaccines Company PaxVax
05/10/2018
GAITHERSBURG, Md., Oct. 04, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has completed its acquisition of PaxVax, a company focused on developing, manufacturing, and [...]

Pages